NBIX Neurocrine Biosciences | $140.09
+4.8% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $150.00 | Low | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
DAWN Day One Biopharmaceuticals | $16.64
+8.2% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/24/2024 |
CLIR ClearSign Technologies | $0.87
+6.1% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 4/24/2024 |
AEYE AudioEye | $13.48
+13.8% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/24/2024 |
OCS Oculis | $11.97
+0.2% | 4/24/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $29.00 -> $28.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 4/24/2024 |
CORT Corcept Therapeutics | $23.00
+3.1% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $38.00 | Low | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 4/23/2024 |
|
GROY Gold Royalty | $2.00
+5.3% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 | N/A | View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 4/23/2024 |
LEGN Legend Biotech | $47.45
+0.8% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/23/2024 |
ATXS Astria Therapeutics | $9.64
-1.6% | 4/23/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.00 -> $16.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 4/23/2024 |
MLTX MoonLake Immunotherapeutics | $43.25
+5.4% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/23/2024 |
BTAI BioXcel Therapeutics | $2.97
+4.2% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 4/23/2024 |
ENLV Enlivex Therapeutics | $1.32
+3.9% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/23/2024 |
RNAC Cartesian Therapeutics | $20.59
+12.8% | 4/23/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $2.00 -> $54.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024 |
KURA Kura Oncology | $18.73
+3.0% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 4/22/2024 |
RIOT Riot Platforms | $11.85
+5.4% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 4/22/2024 |
KRYS Krystal Biotech | $162.04
+3.0% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 | Low | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 4/22/2024 |
CRDL Cardiol Therapeutics | C$2.49
+2.0% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy | | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (TSE:CRDL) on 4/22/2024 |
CLMT Calumet Specialty Products Partners | $16.20
+5.4% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 4/22/2024 |
RVPH Reviva Pharmaceuticals | $3.06
-1.0% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/22/2024 |
LYTS LSI Industries | $14.52
| 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 4/22/2024 |
PHGE BiomX | $0.35
+16.9% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 4/22/2024 |
ROIV Roivant Sciences | $10.94
+3.2% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/22/2024 |
PSTX Poseida Therapeutics | $2.16
+0.5% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 4/22/2024 |
CRDL Cardiol Therapeutics | $1.84
+4.5% | 4/22/2024 | Initiated by | HC Wainwright | Analyst V. Bernardino | Buy | $9.00 | Low | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/22/2024 |
BRNS Barinthus Biotherapeutics | $2.60
-0.8% | 4/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 4/19/2024 |
AG First Majestic Silver | $6.82
+4.1% | 4/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $8.50 | Low | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 4/19/2024 |
ALKS Alkermes | $24.26
+0.8% | 4/19/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $35.00 | Low | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 4/19/2024 |
OCUL Ocular Therapeutix | $5.00
-1.6% | 4/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 4/19/2024 |
TGTX TG Therapeutics | $14.25
+1.1% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $45.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 4/18/2024 |
URGN UroGen Pharma | $14.53
+1.1% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/18/2024 |
BEEM Beam Global | $6.60
+11.3% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Beam Global (NASDAQ:BEEM) on 4/18/2024 |
IGMS IGM Biosciences | $7.70
+14.1% | 4/18/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Neutral -> Neutral | $12.00 | Low | View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 4/18/2024 |
ASM Avino Silver & Gold Mines | $0.70
-2.2% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.60 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024 |
ASM Avino Silver & Gold Mines | $0.72
+3.1% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.60 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024 |
ARGX argenx | $375.08
+1.7% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 4/18/2024 |
AEYE AudioEye | $13.48
+13.8% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $17.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/18/2024 |
ASND Ascendant Resources | C$0.06
| 4/17/2024 | Target Raised by | HC Wainwright | - | | C$0.30 -> C$0.35 | N/A | View details for HC Wainwright rating of Ascendant Resources (TSE:ASND) on 4/17/2024 |
BNTX BioNTech | $88.49
+0.5% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $107.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 4/17/2024 |
ASPI ASP Isotopes | $3.20
+2.2% | 4/17/2024 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $5.25 -> $5.50 | Low | View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 4/17/2024 |
CNTB Connect Biopharma | $1.39
+3.0% | 4/17/2024 | Target Raised by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $7.00 -> $8.00 | Low | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 4/17/2024 |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
CLNN Clene | $0.34
| 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 4/17/2024 |
AEON AEON Biopharma | $4.26
-9.7% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 4/17/2024 |
CLDX Celldex Therapeutics | $37.77
-2.8% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 4/17/2024 |
HALO Halozyme Therapeutics | $38.97
+0.7% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/17/2024 |
SAGE Sage Therapeutics | $12.95
+0.5% | 4/17/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $28.00 | N/A | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/17/2024 |
DTIL Precision BioSciences | $10.23
+5.7% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 4/17/2024 |
BLRX BioLineRx | $0.64
-5.9% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | N/A | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 4/17/2024 |
SABS SAB Biotherapeutics | $4.49
+2.3% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024 |
CMPX Compass Therapeutics | $1.52
+2.0% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/16/2024 |
CGEM Cullinan Oncology | $16.67
+6.7% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $34.00 -> $29.00 | Low | View details for HC Wainwright rating of Cullinan Oncology (NASDAQ:CGEM) on 4/16/2024 |
LEGN Legend Biotech | $47.45
+0.8% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/16/2024 |
MRNS Marinus Pharmaceuticals | $1.44
-2.7% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/16/2024 |
ATOS Atossa Therapeutics | $1.49
+4.9% | 4/16/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 4/16/2024 |
ICCM IceCure Medical | $1.22
| 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 4/16/2024 |
TRNS Transcat | $114.98
+3.3% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $124.00 | Low | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 4/16/2024 |
MITK Mitek Systems | $12.94
+2.1% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 4/16/2024 |
LBPH Longboard Pharmaceuticals | $20.27
+8.6% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | Low | View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/16/2024 |
VIRX Viracta Therapeutics | $0.85
-3.4% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/16/2024 |
TRX TRX Gold | $0.45
-2.2% | 4/16/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.30 -> $1.40 | Low | View details for HC Wainwright rating of TRX Gold (NYSE:TRX) on 4/16/2024 |
UBX Unity Biotechnology | $1.49
+0.7% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 4/16/2024 |
MBOT Microbot Medical | $0.88
-1.1% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $7.00 | Low | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 4/16/2024 |
LFWD ReWalk Robotics | $4.89
| 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 4/15/2024 |
INDP Indaptus Therapeutics | $2.49
+2.0% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Indaptus Therapeutics (NASDAQ:INDP) on 4/15/2024 |
ONCT Oncternal Therapeutics | $8.77
+2.5% | 4/15/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 4/15/2024 |
APLS Apellis Pharmaceuticals | $48.72
+2.3% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $92.00 | Low | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/15/2024 |
CLSK CleanSpark | $20.73
+8.6% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 4/15/2024 |
ADCT ADC Therapeutics | $4.97
+6.2% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 4/15/2024 |
ENLV Enlivex Therapeutics | $1.32
+3.9% | 4/12/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $7.00 | Low | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/12/2024 |
ARVN Arvinas | $34.00
-2.6% | 4/12/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $90.00 -> $87.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 4/12/2024 |
ALPN Alpine Immune Sciences | $64.55
0.0% | 4/11/2024 | Downgraded by | HC Wainwright | Analyst J. Pantginis | Buy -> Neutral | | Low | View details for HC Wainwright rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/11/2024 |
MLTX MoonLake Immunotherapeutics | $43.25
+5.4% | 4/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/11/2024 |
IPHA Innate Pharma | $2.37
-2.1% | 4/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 4/11/2024 |
VRTX Vertex Pharmaceuticals | $404.91
+1.2% | 4/11/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $457.00 -> $462.00 | Low | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/11/2024 |
INAB IN8bio | $1.04
+4.0% | 4/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 4/10/2024 |
ALXO ALX Oncology | $15.50
+8.9% | 4/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 4/10/2024 |
PYXS Pyxis Oncology | $4.50
-0.7% | 4/10/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 4/10/2024 |
FHTX Foghorn Therapeutics | $5.16
+2.2% | 4/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/10/2024 |
RAPT RAPT Therapeutics | $8.00
+1.8% | 4/10/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Neutral | | Low | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 4/10/2024 |
GALT Galectin Therapeutics | $3.38
+10.5% | 4/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/9/2024 |
ELEV Elevation Oncology | $4.32
+6.7% | 4/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 4/9/2024 |
CDTX Cidara Therapeutics | $0.51
| 4/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 | Low | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/8/2024 |
VERV Verve Therapeutics | $6.88
-0.4% | 4/8/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Buy | $15.00 | Low | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 4/8/2024 |
AMLX Amylyx Pharmaceuticals | $1.95
-1.5% | 4/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 4/8/2024 |
TARA Protara Therapeutics | $3.00
-1.6% | 4/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 4/8/2024 |
GNFT Genfit | $3.43
-6.3% | 4/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 4/5/2024 |
CLGN CollPlant Biotechnologies | $5.40
+2.7% | 4/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 4/5/2024 |
AQST Aquestive Therapeutics | $4.28
-2.3% | 4/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/5/2024 |
GMAB Genmab A/S | $28.56
-1.4% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/4/2024 |
AMPX Amprius Technologies | $1.75
+3.6% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Amprius Technologies (NYSE:AMPX) on 4/4/2024 |
MIGI Mawson Infrastructure Group | $1.51
-3.8% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/4/2024 |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
ASXC Asensus Surgical | $0.25
| 4/4/2024 | Downgraded by | HC Wainwright | Analyst S. Ramakanth | Buy -> Neutral | $2.00 -> $0.35 | N/A | View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 4/4/2024 |
CGON CG Oncology | $36.31
+8.3% | 4/4/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 4/4/2024 |
MAG MAG Silver | $12.16
+2.6% | 4/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $19.50 -> $16.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/4/2024 |
FENC Fennec Pharmaceuticals | $9.24
-1.5% | 4/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $18.00 | Low | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 4/4/2024 |
COCP Cocrystal Pharma | $1.56
+2.6% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 4/4/2024 |
ICCM IceCure Medical | $1.22
| 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 4/4/2024 |
URGN UroGen Pharma | $14.53
+1.1% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/4/2024 |
SBEV Splash Beverage Group | $0.32
-3.0% | 4/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.50 -> $1.00 | N/A | View details for HC Wainwright rating of Splash Beverage Group (NYSEAMERICAN:SBEV) on 4/4/2024 |
PHGE BiomX | $0.35
+16.9% | 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 4/3/2024 |
MVST Microvast | $0.46
-9.9% | 4/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $3.00 | Low | View details for HC Wainwright rating of Microvast (NASDAQ:MVST) on 4/3/2024 |
TOMZ TOMI Environmental Solutions | $0.60
| 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.50 | Low | View details for HC Wainwright rating of TOMI Environmental Solutions (NASDAQ:TOMZ) on 4/3/2024 |
FPAY FlexShopper | $1.09
+0.9% | 4/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.50 | Low | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 4/3/2024 |
OPK OPKO Health | $1.25
+1.6% | 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 4/3/2024 |
EVAX Evaxion Biotech A/S | $4.14
-1.2% | 4/3/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 4/3/2024 |
OCGN Ocugen | $1.25
+0.8% | 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 4/3/2024 |
ATAI Atai Life Sciences | $1.97
+5.3% | 4/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $20.00 -> $15.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 4/3/2024 |
ZVRA Zevra Therapeutics | $4.58
+0.2% | 4/3/2024 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/3/2024 |
ROIV Roivant Sciences | $10.94
+3.2% | 4/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/3/2024 |
BKSY BlackSky Technology | $1.23
+2.5% | 4/3/2024 | Initiated by | HC Wainwright | Analyst S. Buck | Buy | $2.50 | Low | View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 4/3/2024 |
MIRM Mirum Pharmaceuticals | $24.42
+1.0% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $58.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 4/2/2024 |
LLAP Terran Orbital | $1.34
+2.3% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Terran Orbital (NYSE:LLAP) on 4/2/2024 |
KALA KALA BIO | $6.50
+2.7% | 4/2/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $21.00 | Low | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 4/2/2024 |
IREN Iris Energy | $5.58
+1.3% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 4/2/2024 |
PPSI Pioneer Power Solutions | $3.76
-4.8% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Pioneer Power Solutions (NASDAQ:PPSI) on 4/2/2024 |
ATOS Atossa Therapeutics | $1.49
+4.9% | 4/2/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 4/2/2024 |
GNLX Genelux | $3.48
+3.9% | 4/2/2024 | Target Lowered by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $35.00 -> $32.00 | Low | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 4/2/2024 |
SABS SAB Biotherapeutics | $4.49
+2.3% | 4/2/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $6.00 | Low | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024 |
ACET Adicet Bio | $2.10
+5.0% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 4/2/2024 |
ALDX Aldeyra Therapeutics | $3.91
-0.5% | 4/2/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/2/2024 |
CARM Carisma Therapeutics | $1.70
-9.1% | 4/2/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 4/2/2024 |
AXSM Axsome Therapeutics | $73.08
+2.8% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $190.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/2/2024 |
ENTX Entera Bio | $2.22
+8.3% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 4/2/2024 |
EQ Equillium | $1.72
+4.2% | 4/2/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.00 -> $5.00 | Low | View details for HC Wainwright rating of Equillium (NASDAQ:EQ) on 4/2/2024 |
ANVS Annovis Bio | $11.91
+3.6% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 4/2/2024 |
GALT Galectin Therapeutics | $3.38
+10.5% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/1/2024 |
ALT Altimmune | $7.57
+1.3% | 4/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $12.00 | Low | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 4/1/2024 |
BMEA Biomea Fusion | $10.98
+1.4% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $6.96
-2.9% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
IRON Disc Medicine | $27.00
+0.1% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 | Low | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 4/1/2024 |
DPRO Draganfly | $0.29
+7.5% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.00 | Low | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 4/1/2024 |
DARE Daré Bioscience | $0.30
| 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 4/1/2024 |
SOL Emeren Group | $1.69
+5.6% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 4/1/2024 |
LEGN Legend Biotech | $47.45
+0.8% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/1/2024 |
ATLX Atlas Lithium | $14.32
+5.9% | 4/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $52.00 -> $40.00 | Low | View details for HC Wainwright rating of Atlas Lithium (NASDAQ:ATLX) on 4/1/2024 |
UNCY Unicycive Therapeutics | $1.07
-7.0% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/1/2024 |
APLM Apollomics | $0.48
| 4/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $17.00 -> $5.00 | Low | View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 4/1/2024 |
ASMB Assembly Biosciences | $13.27
+0.4% | 4/1/2024 | Reiterated by | HC Wainwright | - | Neutral | | Low | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 4/1/2024 |
IVA Inventiva | $3.29
-0.3% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 | Low | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 4/1/2024 |
ITRM Iterum Therapeutics | $1.58
| 4/1/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 4/1/2024 |
CALC CalciMedica | $4.59
+1.8% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
AFMD Affimed | $5.35
+7.0% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
FEMY Femasys | $1.33
+4.7% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $12.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 4/1/2024 |
SLRN Acelyrin | $4.60
-4.6% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 4/1/2024 |
EDAP Edap Tms | $7.09
-0.8% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $19.00 | Low | View details for HC Wainwright rating of Edap Tms (NASDAQ:EDAP) on 4/1/2024 |
LABP Landos Biopharma | $22.15
+0.9% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | $50.00 -> $20.42 | Low | View details for HC Wainwright rating of Landos Biopharma (NASDAQ:LABP) on 4/1/2024 |
GANX Gain Therapeutics | $3.39
+6.9% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 4/1/2024 |
SYRS Syros Pharmaceuticals | $5.14
+3.0% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Syros Pharmaceuticals (NASDAQ:SYRS) on 4/1/2024 |
IMNN Imunon | $1.33
+4.7% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 4/1/2024 |
USIO Usio | $1.48
+0.7% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.50 -> $4.00 | Low | View details for HC Wainwright rating of Usio (NASDAQ:USIO) on 4/1/2024 |
ACRV Acrivon Therapeutics | $9.82
+3.3% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/28/2024 |
HUT Hut 8 | $9.63
+4.4% | 3/28/2024 | Target Raised by | HC Wainwright | Analyst M. Colonnese | Sell -> Sell | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 3/28/2024 |
AKBA Akebia Therapeutics | $1.37
+0.7% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $6.00 | N/A | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/28/2024 |
DTIL Precision BioSciences | $10.23
+5.7% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/28/2024 |
DRRX DURECT | $0.84
+5.0% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral | | Low | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 3/28/2024 |
CELC Celcuity | $17.24
-1.7% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 3/28/2024 |
ERAS Erasca | $1.93
+4.3% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 3/28/2024 |
NUVB Nuvation Bio | $2.67
-0.4% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/28/2024 |
KRRO Korro Bio | $67.94
-0.6% | 3/28/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $100.00 -> $115.00 | Low | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 3/28/2024 |
REE REE Automotive | $3.92
+5.9% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 3/28/2024 |
AQMS Aqua Metals | $0.52
+6.1% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Aqua Metals (NASDAQ:AQMS) on 3/28/2024 |
PPTA Perpetua Resources | $6.27
-0.9% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.50 | Low | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 3/28/2024 |
GLYC GlycoMimetics | $1.84
+1.7% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of GlycoMimetics (NASDAQ:GLYC) on 3/27/2024 |
NVCR NovoCure | $12.06
+1.9% | 3/27/2024 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $22.00 -> $24.00 | Low | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 3/27/2024 |
ATAI Atai Life Sciences | $1.97
+5.3% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 3/27/2024 |
ETNB 89bio | $8.92
-4.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 3/27/2024 |
CLSK CleanSpark | $20.73
+8.6% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 3/27/2024 |
PDSB PDS Biotechnology | $3.20
+7.0% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/27/2024 |
ARGX argenx | $375.08
+1.7% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 3/27/2024 |
ABOS Acumen Pharmaceuticals | $3.16
+1.0% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 3/27/2024 |
VIGL Vigil Neuroscience | $2.65
-6.7% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $24.00 | Low | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/27/2024 |
ANNX Annexon | $4.44
-2.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 3/27/2024 |
WPRT Westport Fuel Systems | $5.81
-0.3% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
EMX EMX Royalty | $1.90
-1.6% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.50 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 3/27/2024 |
FCUUF Fission Uranium | $0.79
+2.6% | 3/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.70 -> $1.90 | Low | View details for HC Wainwright rating of Fission Uranium (OTCMKTS:FCUUF) on 3/27/2024 |
SNDX Syndax Pharmaceuticals | $20.97
+0.0% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 3/27/2024 |
APTO Aptose Biosciences | $1.23
| 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 3/27/2024 |
DCTH Delcath Systems | $5.60
+1.6% | 3/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 3/27/2024 |
BCAB BioAtla | $2.24
+2.8% | 3/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $7.00 | Low | View details for HC Wainwright rating of BioAtla (NASDAQ:BCAB) on 3/27/2024 |
KPRX Kiora Pharmaceuticals | $0.58
+18.4% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Low | View details for HC Wainwright rating of Kiora Pharmaceuticals (NASDAQ:KPRX) on 3/27/2024 |
GMAB Genmab A/S | $28.56
-1.4% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 3/27/2024 |
BLRX BioLineRx | $0.64
-5.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 3/26/2024 |
ATNM Actinium Pharmaceuticals | $6.96
-2.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 3/26/2024 |
PRAX Praxis Precision Medicines | $48.84
+2.2% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 3/26/2024 |
VKTX Viking Therapeutics | $64.93
+1.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
BTDR Bitdeer Technologies Group | $6.71
+0.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/26/2024 |
APRE Aprea Therapeutics | $5.37
+4.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 3/26/2024 |
BITF Bitfarms | $2.11
+2.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/26/2024 |
MRNS Marinus Pharmaceuticals | $1.44
-2.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/26/2024 |
STRO Sutro Biopharma | $3.72
-1.3% | 3/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024 |
STOK Stoke Therapeutics | $11.25
| 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
AXSM Axsome Therapeutics | $73.08
+2.8% | 3/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $180.00 -> $190.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/26/2024 |
BTM Bitcoin Depot | $1.90
-5.0% | 3/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 3/26/2024 |
ADMA ADMA Biologics | $6.54
+5.5% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.50 | Low | View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 3/26/2024 |
ATXS Astria Therapeutics | $9.64
-1.6% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/25/2024 |
ESPR Esperion Therapeutics | $2.09
+9.4% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/25/2024 |
IVVD Invivyd | $2.27
+3.7% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 3/25/2024 |
OTLK Outlook Therapeutics | $8.20
+1.4% | 3/25/2024 | Target Raised by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/25/2024 |
RANI Rani Therapeutics | $6.69
+0.3% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 3/25/2024 |
TIL Instil Bio | $10.60
-1.0% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 3/25/2024 |
BTCS BTCS | $1.53
+1.3% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 3/25/2024 |
LGO Largo | $1.49
+2.1% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $4.60 | Low | View details for HC Wainwright rating of Largo (NYSE:LGO) on 3/25/2024 |
RGLS Regulus Therapeutics | $2.26
+2.7% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/25/2024 |
HOOK Hookipa Pharma | $0.77
+8.5% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.50 | Low | View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 3/25/2024 |
RMTI Rockwell Medical | $1.53
+1.3% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 3/25/2024 |
RVPH Reviva Pharmaceuticals | $3.06
-1.0% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 3/25/2024 |
ABSI Absci | $4.71
+4.4% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 3/22/2024 |
XFOR X4 Pharmaceuticals | $1.23
-9.6% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/22/2024 |
MIST Milestone Pharmaceuticals | $1.70
+4.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 3/22/2024 |
CKPT Checkpoint Therapeutics | $1.44
-0.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/22/2024 |
NXTC NextCure | $1.53
-5.0% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | Low | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/22/2024 |
CBUS Cibus | $15.99
-0.1% | 3/22/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 3/22/2024 |
ASM Avino Silver & Gold Mines | $0.70
-2.2% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.80 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/22/2024 |
ASM Avino Silver & Gold Mines | $0.72
+3.1% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.80 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/22/2024 |
CABA Cabaletta Bio | $13.32
| 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $30.00 | Low | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
IRON Disc Medicine | $27.00
+0.1% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 | Low | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 3/22/2024 |
ARMP Armata Pharmaceuticals | $2.44
-2.8% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 3/22/2024 |
BOLT Bolt Biotherapeutics | $1.11
| 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 3/22/2024 |
ASXC Asensus Surgical | $0.25
| 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 3/22/2024 |
OKYO OKYO Pharma | $1.43
+5.1% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.00 | Low | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 3/22/2024 |
BLTE Belite Bio | $37.00
+7.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/22/2024 |
IDN Intellicheck | $3.16
+2.9% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 3/22/2024 |
IFRX InflaRx | $1.36
-0.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/22/2024 |
PYXS Pyxis Oncology | $4.50
-0.7% | 3/22/2024 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $4.00 -> $7.00 | Low | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 3/22/2024 |
MDWD MediWound | $16.41
+4.1% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 3/22/2024 |
IPHA Innate Pharma | $2.37
-2.1% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 3/22/2024 |
ELDN Eledon Pharmaceuticals | $2.16
+6.9% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/22/2024 |
LYRA Lyra Therapeutics | $5.21
| 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 3/22/2024 |
NKTX Nkarta | $7.56
+2.3% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $20.00 | Low | View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 3/22/2024 |
BRNS Barinthus Biotherapeutics | $2.60
-0.8% | 3/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $8.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 3/21/2024 |
INKT MiNK Therapeutics | $0.87
-2.2% | 3/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $9.00 | Low | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 3/21/2024 |
OABI OmniAb | $4.64
-0.9% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of OmniAb (NASDAQ:OABI) on 3/21/2024 |
CMPX Compass Therapeutics | $1.52
+2.0% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 3/21/2024 |
KOPN Kopin | $0.96
-25.5% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Kopin (NASDAQ:KOPN) on 3/21/2024 |
ORIC ORIC Pharmaceuticals | $8.77
+0.6% | 3/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $21.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/21/2024 |
VZLA Vizsla Silver | $1.35
+0.7% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.25 | Low | View details for HC Wainwright rating of Vizsla Silver (NYSE:VZLA) on 3/21/2024 |
ANVS Annovis Bio | $11.91
+3.6% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 3/21/2024 |
HLVX HilleVax | $12.81
-1.3% | 3/21/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of HilleVax (NASDAQ:HLVX) on 3/21/2024 |
FEMY Femasys | $1.33
+4.7% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/21/2024 |
ANIX Anixa Biosciences | $3.07
+2.0% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 3/21/2024 |
MOGO Mogo | $1.87
+2.2% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/21/2024 |
VALN Valneva | $7.74
-2.3% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 3/21/2024 |
VOR Vor Biopharma | $1.88
+3.3% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.50 | Low | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
SYBX Synlogic | $1.91
+3.8% | 3/20/2024 | Upgraded by | HC Wainwright | Analyst E. Arce | Sell -> Neutral | | Low | View details for HC Wainwright rating of Synlogic (NASDAQ:SYBX) on 3/20/2024 |
SLRN Acelyrin | $4.60
-4.6% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 3/20/2024 |
ACET Adicet Bio | $2.10
+5.0% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 3/20/2024 |
LUMO Lumos Pharma | $2.80
+4.5% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Lumos Pharma (NASDAQ:LUMO) on 3/20/2024 |
IVA Inventiva | $3.29
-0.3% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 | Low | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 3/20/2024 |
BTBT Bit Digital | $2.22
+1.4% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 3/20/2024 |
MAG MAG Silver | $12.16
+2.6% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.50 -> $18.50 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 3/20/2024 |
MITK Mitek Systems | $12.94
+2.1% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 3/20/2024 |
